Heartflow Cash Flow Statement
NASDAQ: HTFLHealth CareMedical/Dental InstrumentsUSD
49.74+2.11 (+4.43%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Heartflow free cash flow
In fiscal 2025, Heartflow generated -$54.0 million of operating cash flow and spent $5.0 million on capital expenditures. That left free cash flow of -$59.0 million, a free-cash-flow margin of -33.5% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Heartflow cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Net Income | -116.79M | -96.43M | -95.66M |
| Net Income growth (YoY) | — | — | — |
| Depreciation & Amortization | 5.44M | 5.36M | 4.74M |
| Stock-Based Compensation | 13.96M | 10.21M | 11.87M |
| Change in Working Capital | -12.62M | -5.17M | -10.33M |
| Operating Cash Flow | -54.02M | -69.00M | -76.43M |
| Capital Expenditures | -5.03M | -4.36M | -6.11M |
| Investing Cash Flow | -238.57M | -4.36M | -6.11M |
| Share Repurchases | — | — | -228.00K |
| Debt Repaid | -115.14M | — | — |
| Financing Cash Flow | 286.04M | 2.24M | 169.32M |
| Net Change in Cash | -6.36M | -71.39M | 86.28M |
| Free Cash Flow | -59.05M | -73.36M | -82.54M |
This table shows 3 annual periods of Heartflow's cash flow statement, from FY 2025 back to FY 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow HTFL's reporting calendar. What is a cash flow statement?